TY - CHAP AU - Maswood M. Ahmad AU - Imad Addin Brema AU - Mussa H. Almalki ED - Mira Siderova Y1 - 2019-05-21 PY - 2019 T1 - SGLT2 Inhibitors Therapy in Type 2 Diabetes Mellitus N2 - The emergence of type 2 diabetes as a global pandemic is one of the major challenges to health care in the 21st century. This book contains chapters covering the newest scientific concepts in the pathogenesis of type 2 diabetes, and the complications and approaches in diagnosis and glycemic control. Part of the book is dedicated to the effect of diabetes on the mental functions and treatment strategies to prevent cognitive decline. Glucose monitoring, using cutting-edge technologies, is outlined, as well as the role of health information technologies in diabetes management. Updates on glucose lowering therapy are presented, and the new emerging class of SGLT2 inhibitors is discussed in detail. The purpose of this book is to disseminate knowledge on type 2 diabetes and to contribute to the professional development of physicians, internists, endocrinologists, medical students, and research scientists in diabetes. BT - Type 2 Diabetes SP - Ch. 5 UR - https://doi.org/10.5772/intechopen.84152 DO - 10.5772/intechopen.84152 SN - 978-1-78923-972-0 PB - IntechOpen CY - Rijeka Y2 - 2024-03-29 ER -